{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:00:45Z","timestamp":1772503245886,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:00:00Z","timestamp":1575072000000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["ZIA HD000139"],"award-info":[{"award-number":["ZIA HD000139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ymgme.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T12:46:50Z","timestamp":1540903610000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-\u03b2-cyclodextrin"],"prefix":"10.1016","volume":"125","author":[{"given":"A.","family":"Cougnoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.10.009_bb0005","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","article-title":"A defect in cholesterol esterification in Niemann-Pick disease (type C) patients","volume":"82","author":"Pentchev","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/humu.20636","article-title":"NPC-db, a Niemann-Pick type C disease gene variation database","volume":"29","author":"Runz","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gim.2015.25","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","volume":"18","author":"Wassif","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-018-0844-0","article-title":"Miglustat in Niemann-Pick disease type C patients: a review","volume":"13","author":"Pineda","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0050","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0055","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2008.10.044","article-title":"Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway","volume":"135","author":"Hitomi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","article-title":"Necroptosis as an alternative form of programmed cell death","volume":"22","author":"Christofferson","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","article-title":"Necroptosis: mechanisms and relevance to disease","volume":"12","author":"Galluzzi","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher's disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0075","doi-asserted-by":"crossref","first-page":"e2147","DOI":"10.1038\/cddis.2016.16","article-title":"Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target","volume":"7","author":"Cougnoux","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/cdd.2012.133","article-title":"Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase","volume":"20","author":"Degterev","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0085","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.4049\/jimmunol.1400499","article-title":"Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice","volume":"192","author":"Berger","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0095","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1128\/MCB.24.4.1464-1469.2004","article-title":"Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4","volume":"24","author":"Newton","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0100","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1084\/jem.20170347","article-title":"RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense","volume":"214","author":"Peterson","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2144\/000112517","article-title":"ImageJ for microscopy","volume":"43","author":"Collins","year":"2007","journal-title":"BioTechniques"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0110","doi-asserted-by":"crossref","first-page":"40531","DOI":"10.18632\/oncotarget.9643","article-title":"Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models","volume":"7","author":"Bullova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2014.03.001","article-title":"Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice","volume":"67","author":"Williams","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0130","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","article-title":"The death domain kinase RIP mediates the TNF-induced NF-kappaB signal","volume":"8","author":"Kelliher","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0140","doi-asserted-by":"crossref","first-page":"276ra226","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0145","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1101\/gad.1984410","article-title":"Alternative cell death mechanisms in development and beyond","volume":"24","author":"Yuan","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jnr.10257","article-title":"Studies on neuronal death in the mouse model of Niemann-Pick C disease","volume":"68","author":"Erickson","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0155","article-title":"Life after death: RIP1 and RIP3 move beyond necroptosis","volume":"2","author":"Berger","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0160","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1038\/cddis.2012.64","article-title":"A novel role for RIP1 kinase in mediating TNFalpha production","volume":"3","author":"Christofferson","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0165","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1523\/JNEUROSCI.5282-06.2007","volume":"27","author":"Suzuki","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0170","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/hmg\/ddy112","article-title":"Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention","volume":"27","author":"Cougnoux","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2009.07.010","article-title":"Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1","volume":"36","author":"Smith","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbrc.2011.08.096","article-title":"Npc1 deficiency in the C57BL\/6J genetic background enhances Niemann-Pick disease type C spleen pathology","volume":"413","author":"Parra","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0185","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.ymgme.2018.10.009_bb0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0001-706X(01)00153-X","article-title":"Cellular immune responses and cytokine production in BALB\/c and C57BL\/6 mice during the acute phase of Angiostrongylus costaricensis infection","volume":"80","author":"Geiger","year":"2001","journal-title":"Acta Trop."},{"key":"10.1016\/j.ymgme.2018.10.009_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet. Pathol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218305456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218305456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:22:24Z","timestamp":1761088944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218305456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1096719218305456"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.10.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-\u03b2-cyclodextrin","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}